-
521
Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjun...
Published 2023-11-01“…María Cecilia Marini,1 Martín Lucas Berra,2 Fernada Girado,3 Paula Alejandra Albera,4 Melina Sol del Papa,5 María Silvia Passerini,5 Alejandro Javier Aguilar6 1Ophthalmology Service, El Cruce-Nestor Kirchner High Complexity Hospital, Buenos Aires, Argentina; 2Cornea Transplant Service, Pedro Lagleyze Institute, Autonomous City of Buenos Aires, Argentina; 3Ophthalmology Service, Churruca-Visca Police Medical Complex, Autonomous City of Buenos Aires, Argentina; 4Ocular Surface Service, Santa Lucia Ophthalmological Hospital, Autonomous City of Buenos Aires, Argentina; 5Medical Affairs Department, Poen Laboratories, Autonomous City of Buenos Aires, Argentina; 6Ocular Surface Service, Lomas de San Isidro Medical Group, Buenos Aires, ArgentinaCorrespondence: Melina Sol del Papa, Medical Affairs Department, Poen Laboratories, Gómez de Fonseca 652, Autonomous City of Buenos Aires, C1407 ATL, Argentina, Tel +54 946 700100, Email investigacion@poen.net.arPurpose: To study the efficacy and toxic effects of bepotastine besilate 1.5% preservative-free (BB-PF) and olopatadine 0.2% BAK-preserved (OL-BAK) drops on the ocular surface of patients with allergic conjunctivitis.Patients and Methods: Ninety-seven patients with allergic conjunctivitis diagnosis participated in a prospective, multicenter, randomized, double-blind, controlled, parallel-group clinical trial. …”
Get full text
Article -
522
-
523
-
524
-
525
-
526
Sperm Quality Affected by Naturally Occurring Chemical Elements in Bull Seminal Plasma
Published 2022-09-01Get full text
Article -
527
-
528
Lung Nodules Missed in Initial Staging of Breast Cancer Patients in PET/MRI—Clinically Relevant?
Published 2022-07-01Get full text
Article -
529
Phenology and morphology of the invasive legume Lupinus polyphyllus along a latitudinal gradient in Europe
Published 2022-12-01Get full text
Article -
530
-
531
-
532
Evaluating registry-based trial economics: Results from the STRESS clinical trial
Published 2024-04-01Get full text
Article -
533
-
534
-
535
Improving uncertainty in forest carbon accounting for REDD+ mitigation efforts
Published 2020-01-01Get full text
Article -
536
-
537
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)
Published 2022-06-01Get full text
Article -
538
-
539
-
540
Measuring the predictability of life outcomes with a scientific mass collaboration
Published 2021Get full text
Article